Rebalix
Vanguard · sheet of 4 September 2026
Vanguard · sheet of 4 September 2026ETF sheet · official issuer and register data
Vanguard LifeStrategy 80% Equity UCITS ETF (EUR) Distributing
VNGD80 · IE00BMVB5S82 · EUR · domicile Ireland
Multi-assetactivebond sleeve hedged to EURSFDR art. 6 (inferred)
Comparison benchmark: issuer internal composite (multi-asset)
- TER
- 0.25%+ trans. 0.05%
- Fund size
- 1.3 bn EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 24.32%white list 12.45%
- Replication
- Gestione attiva (dal KID)active management
- Income
- Distributingsemi-annual
Launch 8 Dec 2020 · costs from the KID as of 2 Sept 2026 · 14 securities held · 10 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Fund seeks to provide a combination of long-term capital appreciation with some income by investing in equity and fixed income securities, primarily through investment in other collective investment schemes. The Fund pursues an actively-managed investment strategy whereby the Investment Manager has discretion over the composition of the Fund's portfolio holdings and is not managed with reference to a benchmark index. However, as more particularly described below, the Investment Manager manages the Fund through pre-determined asset allocations to…
Performance since series start (in euro) — base 100
31 Jan 2021 → 31 Jul 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +20.4% |
| 3 years | +46.5% |
| 5 years | +53.1% |
| 10 years | series too young |
| Since series start | +71.4% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 8.29% | 9.68% | 10.59% |
| Max drawdown | −5.79% | −15.63% | −16.48% |
| Sharpe | 1.54 | 0.88 | 0.40 |
| Sortino | 2.22 | 1.21 | 0.54 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · VNGD80 · IE00BMVB5S821
RebalixVNGD80 · IE00BMVB5S82 · sheet of 4 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication
Distributions · per share, in EUR
Frequency: semi-annual · last 12 months: 0.733 EUR (1.86% of NAV) · last ex-date 18 Jun 2026
| Year | Payments | Total (EUR) | Dividend yield |
|---|---|---|---|
| 2026 | 1 | 0.3579 | — |
| 2025 | 2 | 0.7082 | +2.10% |
| 2024 | 2 | 0.654 | +2.28% |
| 2023 | 2 | 0.5788 | +2.28% |
| 2022 | 2 | 0.5349 | +1.79% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 31 Jul 2026 · 14 securities · top-10 weight = 99.6%
| Top holdings | Weight |
|---|---|
| 19.4% | |
| 19.3% | |
| 19.2% | |
| 19.1% | |
| 6.3% | |
| 6.1% | |
| 5.6% | |
| 2.3% | |
| 2.1% | |
| 0.2% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
VNGD80 · Borsa Italiana (ETFplus)
V80D · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Euronext Amsterdam, Tradegate Exchange, Xetra (Deutsche Börse)
+ 9 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · fund-docs.vanguard.com/etf-prospectus-en.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00BMVB5S82
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BMVB5S82
Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · VNGD80 · IE00BMVB5S822